ID   SW480
AC   CVCL_0546
SY   SW-480; SW 480; SW480E
DR   BTO; BTO:0000038
DR   CLO; CLO_0009195
DR   CLO; CLO_0009217
DR   CLO; CLO_0009218
DR   EFO; EFO_0002083
DR   MCCL; MCC:0000447
DR   CLDB; cl4440
DR   CLDB; cl4441
DR   CLDB; cl4966
DR   AddexBio; C0009001/43
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CCL-228
DR   BCRC; 60249
DR   BioSample; SAMN01821602
DR   BioSample; SAMN03481110
DR   BioSample; SAMN05292431
DR   BioSample; SAMN07709984
DR   BioSample; SAMN07709985
DR   BioSample; SAMN07709986
DR   BioSample; SAMN07709987
DR   BioSample; SAMN07709988
DR   BioSample; SAMN07709989
DR   BioSample; SAMN07709990
DR   BioSample; SAMN10987646
DR   CCRID; 3111C0001CCC000166
DR   CCRID; 3131C0001000700086
DR   CCRID; 3131C0001000700172
DR   CCRID; 3142C0001000000064
DR   Cell_Model_Passport; SIDM00840
DR   ChEMBL-Cells; CHEMBL3307758
DR   ChEMBL-Targets; CHEMBL612544
DR   CLS; 300302/p716_SW-480
DR   ColonAtlas; SW480
DR   Cosmic; 709847
DR   Cosmic; 711272
DR   Cosmic; 716169
DR   Cosmic; 720332
DR   Cosmic; 875293
DR   Cosmic; 876719
DR   Cosmic; 887240
DR   Cosmic; 889536
DR   Cosmic; 902791
DR   Cosmic; 905006
DR   Cosmic; 913892
DR   Cosmic; 948827
DR   Cosmic; 983732
DR   Cosmic; 985652
DR   Cosmic; 990302
DR   Cosmic; 995393
DR   Cosmic; 1043829
DR   Cosmic; 1057764
DR   Cosmic; 1066212
DR   Cosmic; 1071888
DR   Cosmic; 1122332
DR   Cosmic; 1132573
DR   Cosmic; 1132693
DR   Cosmic; 1154645
DR   Cosmic; 1176589
DR   Cosmic; 1184095
DR   Cosmic; 1184328
DR   Cosmic; 1187323
DR   Cosmic; 1223149
DR   Cosmic; 1310935
DR   Cosmic; 1332007
DR   Cosmic; 1374642
DR   Cosmic; 1466822
DR   Cosmic; 1479588
DR   Cosmic; 1482524
DR   Cosmic; 1486130
DR   Cosmic; 1524329
DR   Cosmic; 1552183
DR   Cosmic; 1571768
DR   Cosmic; 1609479
DR   Cosmic; 1676750
DR   Cosmic; 1708398
DR   Cosmic; 1803951
DR   Cosmic; 2036653
DR   Cosmic; 2145577
DR   Cosmic; 2156941
DR   Cosmic; 2267318
DR   Cosmic; 2301547
DR   Cosmic; 2302018
DR   Cosmic; 2433752
DR   Cosmic; 2646770
DR   Cosmic; 2651869
DR   Cosmic; 2664054
DR   Cosmic; 2668252
DR   Cosmic; 2727482
DR   DepMap; ACH-000842
DR   DSMZ; ACC-313
DR   ECACC; 87092801
DR   FCS-free; 180-2-342-3-16-3
DR   GEO; GSM206552
DR   GEO; GSM274771
DR   GEO; GSM274772
DR   GEO; GSM513930
DR   GEO; GSM514312
DR   GEO; GSM741258
DR   GEO; GSM784022
DR   GEO; GSM861349
DR   GEO; GSM861350
DR   GEO; GSM861351
DR   GEO; GSM861352
DR   GEO; GSM887674
DR   GEO; GSM888766
DR   GEO; GSM1006234
DR   GEO; GSM1006235
DR   GEO; GSM1346891
DR   GEO; GSM1374928
DR   GEO; GSM1374929
DR   GEO; GSM1374930
DR   GEO; GSM1448166
DR   GEO; GSM1670508
DR   GEO; GSM1862124
DR   GEO; GSM1862125
DR   GEO; GSM1862126
DR   GEO; GSM2299788
DR   GEO; GSM2550016
DR   IARC_TP53; 96
DR   IARC_TP53; 23572
DR   ICLC; HTL99017
DR   IGRhCellID; SW480
DR   KCB; KCB 200848YJ
DR   KCLB; 10228
DR   LiGeA; CCLE_461
DR   Lonza; 816
DR   MetaboLights; MTBLS227
DR   NCBI_Iran; C506
DR   PharmacoDB; SW480_1539_2019
DR   PRIDE; PXD000089
DR   PRIDE; PXD000230
DR   PRIDE; PXD001550
DR   PRIDE; PXD002793
DR   PRIDE; PXD003708
DR   PRIDE; PXD005354
DR   PRIDE; PXD006662
DR   PRIDE; PXD019478
DR   PRIDE; PXD019479
DR   RCB; RCB1959
DR   TKG; TKG 0505
DR   TOKU-E; 3233
DR   Wikidata; Q28472974
RX   PubMed=288927;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=1389533;
RX   PubMed=1778766;
RX   PubMed=3349466;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=7104989;
RX   PubMed=7459858;
RX   PubMed=7651727;
RX   PubMed=7824277;
RX   PubMed=8422623;
RX   PubMed=8895552;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9290701;
RX   PubMed=9294210;
RX   PubMed=9715273;
RX   PubMed=10612807;
RX   PubMed=10674020;
RX   PubMed=10737795;
RX   PubMed=10773689;
RX   PubMed=11113861;
RX   PubMed=11226274;
RX   PubMed=11414198;
RX   PubMed=11526487;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=19927377;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=20831567;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=23932154;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=24840470;
RX   PubMed=25485619;
RX   PubMed=25841592;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=27987026;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=29101300;
RX   PubMed=29131639;
RX   PubMed=30894373;
RX   PubMed=31059103;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32172478;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Doubling time: 50 hours, at 73th passage (PubMed=1000501); 24 hours (PubMed=25984343); 20-25 hours (CLS); ~25-30 hours (DSMZ); ~38 hours (PBCF).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=10674020; PubMed=24042735; PubMed=25926053; PubMed=28683746).
CC   Sequence variation: Homozygous for APC p.Gln1338Ter (c.4012C>T) (PubMed=24755471; APC).
CC   Sequence variation: Homozygous for KRAS p.Gly12Val (c.35G>T) (ClinVar=VCV000012583) (PubMed=20570890; PubMed=24755471; PubMed=28683746; CCLE).
CC   Sequence variation: Heterozygous for TP53 p.Arg273His (c.818G>A) (ClinVar=VCV000012366) and p.Pro309Ser (c.925C>T) (PubMed=7651727; PubMed=9715273; PubMed=16418264; PubMed=24755471; PubMed=28683746; CCLE).
CC   Omics: Deep exome analysis.
CC   Omics: Deep phosphoproteome analysis.
CC   Omics: Deep proteome analysis.
CC   Omics: Deep quantitative proteome analysis.
CC   Omics: Deep RNAseq analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: miRNA expression profiling.
CC   Omics: N-glycan profiling.
CC   Omics: Nuclear proteome analysis.
CC   Omics: O-glycan profiling.
CC   Omics: Protein expression by reverse-phase protein arrays.
CC   Omics: shRNA library screening.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis.
CC   Genome ancestry: African=0%; Native American=0.55%; East Asian, North=1.14%; East Asian, South=0.1%; South Asian=0.15%; European, North=58.36%; European, South=39.69% (PubMed=30894373).
CC   Misspelling: WE-480; In PubMed=12761194.
CC   Misspelling: WE480; In PubMed=12761194.
CC   Misspelling: SW80; Occasionally.
CC   Discontinued: RCB; RCB1959; true.
CC   Discontinued: TKG; TKG 0505; true.
ST   Source(s): AddexBio; ATCC; CCRID; CLS; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,15
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-07-20; Version: 34
RX   PubMed=288927; DOI=10.1093/jnci/63.3.635;
RA   Leibovitz A., Wright W.C., Pathak S., Siciliano M.J., Daniels W.P.,
RA   Fogh H., Fogh J.;
RT   "Detection and analysis of a glucose 6-phosphate dehydrogenase
RT   phenotype B cell line contamination.";
RL   J. Natl. Cancer Inst. 63:635-645(1979).
RX   PubMed=327080; DOI=10.1093/jnci/59.1.221;
RA   Fogh J., Fogh J.M., Orfeo T.;
RT   "One hundred and twenty-seven cultured human tumor cell lines
RT   producing tumors in nude mice.";
RL   J. Natl. Cancer Inst. 59:221-226(1977).
RX   PubMed=833871; DOI=10.1093/jnci/58.2.209;
RA   Fogh J., Wright W.C., Loveless J.D.;
RT   "Absence of HeLa cell contamination in 169 cell lines derived from
RT   human tumors.";
RL   J. Natl. Cancer Inst. 58:209-214(1977).
RX   PubMed=924690; DOI=10.1002/ijc.2910200505;
RA   Kerbel R.S., Pross H.F., Leibovitz A.;
RT   "Analysis of established human carcinoma cell lines for
RT   lymphoreticular-associated membrane receptors.";
RL   Int. J. Cancer 20:673-679(1977).
RX   PubMed=1000501;
RA   Leibovitz A., Stinson J.C., McCombs W.B. III, McCoy C.E., Mazur K.C.,
RA   Mabry N.D.;
RT   "Classification of human colorectal adenocarcinoma cell lines.";
RL   Cancer Res. 36:4562-4569(1976).
RX   PubMed=1389533; DOI=10.1016/0959-8049(92)90031-V;
RA   Lahm H., Petral-Malec D., Yilmaz-Ceyhan A., Fischer J.R.,
RA   Lorenzoni M., Givel J.-C., Odartchenko N.;
RT   "Growth stimulation of a human colorectal carcinoma cell line by
RT   interleukin-1 and -6 and antagonistic effects of transforming growth
RT   factor beta 1.";
RL   Eur. J. Cancer 28:1894-1899(1992).
RX   PubMed=1778766; DOI=10.1111/j.1349-7006.1991.tb01816.x;
RA   Takeshima E., Hamaguchi M., Watanabe T., Akiyama S., Kataoka M.,
RA   Ohnishi Y., Xiao H.Y., Nagai Y., Takagi H.;
RT   "Aberrant elevation of tyrosine-specific phosphorylation in human
RT   gastric cancer cells.";
RL   Jpn. J. Cancer Res. 82:1428-1435(1991).
RX   PubMed=3349466;
RA   Chantret I., Barbat A., Dussaulx E., Brattain M.G., Zweibaum A.;
RT   "Epithelial polarity, villin expression, and enterocytic
RT   differentiation of cultured human colon carcinoma cells: a survey of
RT   twenty cell lines.";
RL   Cancer Res. 48:1936-1942(1988).
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
RX   PubMed=6582512; DOI=10.1073/pnas.81.2.568;
RA   Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.;
RT   "Cell surface antigens of human ovarian and endometrial carcinoma
RT   defined by mouse monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984).
RX   PubMed=7104989; DOI=10.1016/0165-4608(82)90076-0;
RA   Chen T.-R., Hay R.J., Macy M.L.;
RT   "Karyotype consistency in human colorectal carcinoma cell lines
RT   established in vitro.";
RL   Cancer Genet. Cytogenet. 6:93-117(1982).
RX   PubMed=7459858;
RA   Rousset M., Zweibaum A., Fogh J.;
RT   "Presence of glycogen and growth-related variations in 58 cultured
RT   human tumor cell lines of various tissue origins.";
RL   Cancer Res. 41:1165-1170(1981).
RX   PubMed=7651727;
RA   Kastrinakis W.V., Ramchurren N., Rieger K.M., Hess D.T., Loda M.,
RA   Steele G., Summerhayes I.C.;
RT   "Increased incidence of p53 mutations is associated with hepatic
RT   metastasis in colorectal neoplastic progression.";
RL   Oncogene 11:647-652(1995).
RX   PubMed=7824277;
RA   Eshleman J.R., Lang E.Z., Bowerfind G.K., Parsons R., Vogelstein B.,
RA   Willson J.K.V., Veigl M.L., Sedwick W.D., Markowitz S.D.;
RT   "Increased mutation rate at the hprt locus accompanies microsatellite
RT   instability in colon cancer.";
RL   Oncogene 10:33-37(1995).
RX   PubMed=8422623; DOI=10.1002/1097-0142(19930115)71:2<315::AID-CNCR2820710208>3.0.CO;2-B;
RA   Tibbetts L.M., Doremus C.M., Tzanakakis G.N., Vezeridis M.P.;
RT   "Liver metastases with 10 human colon carcinoma cell lines in nude
RT   mice and association with carcinoembryonic antigen production.";
RL   Cancer 71:315-321(1993).
RX   PubMed=8895552; DOI=10.1002/(SICI)1097-0215(19960927)68:1<126::AID-IJC22>3.0.CO;2-8;
RA   Suardet L., Li C., Little J.B.;
RT   "Radio-induced modulation of transforming growth factor beta1
RT   sensitivity in a p53 wild-type human colorectal-cancer cell line.";
RL   Int. J. Cancer 68:126-131(1996).
RX   PubMed=9000147;
RA   Cottu P.H., Muzeau F., Estreicher A., Flejou J.-F., Iggo R.D.,
RA   Thomas G., Hamelin R.;
RT   "Inverse correlation between RER+ status and p53 mutation in
RT   colorectal cancer cell lines.";
RL   Oncogene 13:2727-2730(1996).
RX   PubMed=9000572;
RA   Hoang J.-M., Cottu P.H., Thuille B., Salmon R.J., Thomas G.,
RA   Hamelin R.;
RT   "BAT-26, an indicator of the replication error phenotype in colorectal
RT   cancers and cell lines.";
RL   Cancer Res. 57:300-303(1997).
RX   PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D;
RA   Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T.,
RA   Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M.,
RA   Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.;
RT   "Screening the p53 status of human cell lines using a yeast functional
RT   assay.";
RL   Mol. Carcinog. 19:243-253(1997).
RX   PubMed=9294210; DOI=10.1073/pnas.94.19.10330;
RA   Ilyas M., Tomlinson I.P.M., Rowan A., Pignatelli M., Bodmer W.F.;
RT   "Beta-catenin mutations in cell lines established from human
RT   colorectal cancers.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:10330-10334(1997).
RX   PubMed=9715273; DOI=10.1038/sj.onc.1201986;
RA   Eshleman J.R., Casey G., Kochera M.E., Sedwick W.D., Swinler S.E.,
RA   Veigl M.L., Willson J.K.V., Schwartz S., Markowitz S.D.;
RT   "Chromosome number and structure both are markedly stable in RER
RT   colorectal cancers and are not destabilized by mutation of p53.";
RL   Oncogene 17:719-725(1998).
RX   PubMed=10612807; DOI=10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P;
RA   Ghadimi B.M., Sackett D.L., Difilippantonio M.J., Schrock E.,
RA   Neumann T., Jauho A., Auer G., Ried T.;
RT   "Centrosome amplification and instability occurs exclusively in
RT   aneuploid, but not in diploid colorectal cancer cell lines, and
RT   correlates with numerical chromosomal aberrations.";
RL   Genes Chromosomes Cancer 27:183-190(2000).
RX   PubMed=10674020; DOI=10.1016/S0959-8049(99)00206-3;
RA   Ku J.-L., Yoon K.-A., Kim D.-Y., Park J.-G.;
RT   "Mutations in hMSH6 alone are not sufficient to cause the
RT   microsatellite instability in colorectal cancer cell lines.";
RL   Eur. J. Cancer 35:1724-1729(1999).
RX   PubMed=10737795; DOI=10.1073/pnas.97.7.3352;
RA   Rowan A.J., Lamlum H., Ilyas M., Wheeler J., Straub J.,
RA   Papadopoulou A., Bicknell D.C., Bodmer W.F., Tomlinson I.P.M.;
RT   "APC mutations in sporadic colorectal tumors: a mutational 'hotspot'
RT   and interdependence of the 'two hits'.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:3352-3357(2000).
RX   PubMed=10773689; DOI=10.1159/000015508;
RA   Melcher R., Steinlein C., Feichtinger W., Muller C.R., Menzel T.,
RA   Luhrs H., Scheppach W., Schmid M.;
RT   "Spectral karyotyping of the human colon cancer cell lines SW480 and
RT   SW620.";
RL   Cytogenet. Cell Genet. 88:145-152(2000).
RX   PubMed=11113861; DOI=10.1002/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K;
RA   Hewitt R.E., McMarlin A., Kleiner D., Wersto R., Martin P., Tsokos M.,
RA   Stamp G.W.H., Stetler-Stevenson W.G.;
RT   "Validation of a model of colon cancer progression.";
RL   J. Pathol. 192:446-454(2000).
RX   PubMed=11226274; DOI=10.1073/pnas.041603298;
RA   Abdel-Rahman W.M., Katsura K., Rens W., Gorman P.A., Sheer D.,
RA   Bicknell D.C., Bodmer W.F., Arends M.J., Wyllie A.H., Edwards P.A.W.;
RT   "Spectral karyotyping suggests additional subsets of colorectal
RT   cancers characterized by pattern of chromosome rearrangement.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:2538-2543(2001).
RX   PubMed=11414198; DOI=10.1007/s004320000207;
RA   Lahm H., Andre S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H.,
RA   Wolf E., Gabius H.J.;
RT   "Comprehensive galectin fingerprinting in a panel of 61 human tumor
RT   cell lines by RT-PCR and its implications for diagnostic and
RT   therapeutic procedures.";
RL   J. Cancer Res. Clin. Oncol. 127:375-386(2001).
RX   PubMed=11526487; DOI=10.1038/sj.onc.1204611;
RA   Gayet J., Zhou X.-P., Duval A., Rolland S., Hoang J.-M., Cottu P.H.,
RA   Hamelin R.;
RT   "Extensive characterization of genetic alterations in a series of
RT   human colorectal cancer cell lines.";
RL   Oncogene 20:5025-5032(2001).
RX   PubMed=16418264; DOI=10.1073/pnas.0510146103;
RA   Liu Y., Bodmer W.F.;
RT   "Analysis of P53 mutations and their expression in 56 colorectal
RT   cancer cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:976-981(2006).
RX   PubMed=16854228; DOI=10.1186/1476-4598-5-29;
RA   Bandres E., Cubedo E., Agirre X., Malumbres R., Zarate R., Ramirez N.,
RA   Abajo A., Navarro A., Moreno I., Monzo M., Garcia-Foncillas J.;
RT   "Identification by real-time PCR of 13 mature microRNAs differentially
RT   expressed in colorectal cancer and non-tumoral tissues.";
RL   Mol. Cancer 5:29-29(2006).
RX   PubMed=19927377; DOI=10.1002/gcc.20730;
RA   Knutsen T., Padilla-Nash H.M., Wangsa D., Barenboim-Stapleton L.,
RA   Camps J., McNeil N.E., Difilippantonio M.J., Ried T.;
RT   "Definitive molecular cytogenetic characterization of 15 colorectal
RT   cancer cell lines.";
RL   Genes Chromosomes Cancer 49:204-223(2010).
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
RX   PubMed=20570890; DOI=10.1158/0008-5472.CAN-10-0192;
RA   Janakiraman M., Vakiani E., Zeng Z., Pratilas C.A., Taylor B.S.,
RA   Chitale D., Halilovic E., Wilson M., Huberman K., Ricarte Filho J.C.,
RA   Persaud Y., Levine D.A., Fagin J.A., Jhanwar S.C., Mariadason J.M.,
RA   Lash A., Ladanyi M., Saltz L.B., Heguy A., Paty P.B., Solit D.B.;
RT   "Genomic and biological characterization of exon 4 KRAS mutations in
RT   human cancer.";
RL   Cancer Res. 70:5901-5911(2010).
RX   PubMed=20606684; DOI=10.1038/sj.bjc.6605780;
RA   Bracht K., Nicholls A.M., Liu Y., Bodmer W.F.;
RT   "5-fluorouracil response in a large panel of colorectal cancer cell
RT   lines is associated with mismatch repair deficiency.";
RL   Br. J. Cancer 103:340-346(2010).
RX   PubMed=20831567; DOI=10.1111/j.1582-4934.2010.01170.x;
RA   Ma Y.-L., Zhang P., Wang F., Moyer M.P., Yang J.-J., Liu Z.-H.,
RA   Peng J.-Y., Chen H.-Q., Zhou Y.-K., Liu W.-J., Qin H.-L.;
RT   "Human embryonic stem cells and metastatic colorectal cancer cells
RT   shared the common endogenous human microRNA-26b.";
RL   J. Cell. Mol. Med. 15:1941-1954(2011).
RX   PubMed=22460905; DOI=10.1038/nature11003;
RA   Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A.,
RA   Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A.,
RA   Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J.,
RA   Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E.,
RA   Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J.,
RA   Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C.,
RA   Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C.,
RA   Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N., Mesirov J.P.,
RA   Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L.,
RA   Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R.,
RA   Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.;
RT   "The Cancer Cell Line Encyclopedia enables predictive modelling of
RT   anticancer drug sensitivity.";
RL   Nature 483:603-607(2012).
RX   PubMed=23272949; DOI=10.1186/1755-8794-5-66;
RA   Schlicker A., Beran G., Chresta C.M., McWalter G., Pritchard A.,
RA   Weston S., Runswick S., Davenport S., Heathcote K., Castro D.A.,
RA   Orphanides G., French T., Wessels L.F.A.;
RT   "Subtypes of primary colorectal tumors correlate with response to
RT   targeted treatment in colorectal cell lines.";
RL   BMC Med. Genomics 5:66-66(2012).
RX   PubMed=23932154; DOI=10.1016/j.radonc.2013.06.032;
RA   Salendo J., Spitzner M., Kramer F., Zhang X., Jo P., Wolff H.A.,
RA   Kitz J., Kaulfuss S., Beissbarth T., Dobbelstein M., Ghadimi M.,
RA   Grade M., Gaedcke J.;
RT   "Identification of a microRNA expression signature for
RT   chemoradiosensitivity of colorectal cancer cells, involving
RT   miRNAs-320a, -224, -132 and let7g.";
RL   Radiother. Oncol. 108:451-457(2013).
RX   PubMed=24042735; DOI=10.1038/oncsis.2013.35;
RA   Ahmed D., Eide P.W., Eilertsen I.A., Danielsen S.A., Eknaes M.,
RA   Hektoen M., Lind G.E., Lothe R.A.;
RT   "Epigenetic and genetic features of 24 colon cancer cell lines.";
RL   Oncogenesis 2:E71-E71(2013).
RX   PubMed=24755471; DOI=10.1158/0008-5472.CAN-14-0013;
RA   Mouradov D., Sloggett C., Jorissen R.N., Love C.G., Li S.,
RA   Burgess A.W., Arango D., Strausberg R.L., Buchanan D., Wormald S.,
RA   O'Connor L., Wilding J.L., Bicknell D.C., Tomlinson I.P.M., Bodmer W.F.,
RA   Mariadason J.M., Sieber O.M.;
RT   "Colorectal cancer cell lines are representative models of the main
RT   molecular subtypes of primary cancer.";
RL   Cancer Res. 74:3238-3247(2014).
RX   PubMed=24840470; DOI=10.1016/j.jprot.2014.05.002;
RA   Chik J.H.L., Zhou J., Moh E.S.X., Christopherson R., Clarke S.J.,
RA   Molloy M.P., Packer N.H.;
RT   "Comprehensive glycomics comparison between colon cancer cell cultures
RT   and tumours: implications for biomarker studies.";
RL   J. Proteomics 108:146-162(2014).
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z., Liu H.,
RA   Degenhardt J., Mayba O., Gnad F., Liu J., Pau G., Reeder J., Cao Y.,
RA   Mukhyala K., Selvaraj S.K., Yu M., Zynda G.J., Brauer M.J., Wu T.D.,
RA   Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D.,
RA   Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S.,
RA   Zhang Z.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
RX   PubMed=25841592; DOI=10.1016/j.jprot.2015.03.019;
RA   Piersma S.R., Knol J.C., de Reus I., Labots M., Sampadi B.K.,
RA   Pham T.V., Ishihama Y., Verheul H.M.W., Jimenez C.R.;
RT   "Feasibility of label-free phosphoproteomics and application to
RT   base-line signaling of colorectal cancer cell lines.";
RL   J. Proteomics 127:247-258(2015).
RX   PubMed=25926053; DOI=10.1038/ncomms8002;
RA   Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G.,
RA   Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S.,
RA   Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M.,
RA   Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.;
RT   "The molecular landscape of colorectal cancer cell lines unveils
RT   clinically actionable kinase targets.";
RL   Nat. Commun. 6:7002-7002(2015).
RX   PubMed=25984343; DOI=10.1038/sdata.2014.35;
RA   Cowley G.S., Weir B.A., Vazquez F., Tamayo P., Scott J.A., Rusin S.,
RA   East-Seletsky A., Ali L.D., Gerath W.F.J., Pantel S.E., Lizotte P.H.,
RA   Jiang G., Hsiao J., Tsherniak A., Dwinell E., Aoyama S., Okamoto M.,
RA   Harrington W., Gelfand E., Green T.M., Tomko M.J., Gopal S.,
RA   Wong T.C., Li H., Howell S., Stransky N., Liefeld T., Jang D.,
RA   Bistline J., Hill Meyers B., Armstrong S.A., Anderson K.C.,
RA   Stegmaier K., Reich M., Pellman D., Boehm J.S., Mesirov J.P.,
RA   Golub T.R., Root D.E., Hahn W.C.;
RT   "Parallel genome-scale loss of function screens in 216 cancer cell
RT   lines for the identification of context-specific genetic
RT   dependencies.";
RL   Sci. Data 1:140035-140035(2014).
RX   PubMed=26537799; DOI=10.1074/mcp.M115.051235;
RA   Holst S., Deuss A.J.M., van Pelt G.W., van Vliet S.J.,
RA   Garcia-Vallejo J.J., Koeleman C.A.M., Deelder A.M., Mesker W.E.,
RA   Tollenaar R.A., Rombouts Y., Wuhrer M.;
RT   "N-glycosylation profiling of colorectal cancer cell lines reveals
RT   association of fucosylation with differentiation and caudal type
RT   homebox 1 (CDX1)/villin mRNA expression.";
RL   Mol. Cell. Proteomics 15:124-140(2016).
RX   PubMed=27987026; DOI=10.1007/s00216-016-0125-5;
RA   Schunter A.J., Yue X., Hummon A.B.;
RT   "Phosphoproteomics of colon cancer metastasis: comparative mass
RT   spectrometric analysis of the isogenic primary and metastatic cell
RT   lines SW480 and SW620.";
RL   Anal. Bioanal. Chem. 409:1749-1763(2017).
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005;
RA   Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P.,
RA   Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W.,
RA   Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D.,
RA   Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B.,
RA   Liang H.;
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
RX   PubMed=28683746; DOI=10.1186/s12943-017-0691-y;
RA   Berg K.C.G., Eide P.W., Eilertsen I.A., Johannessen B., Bruun J.,
RA   Danielsen S.A., Bjornslett M., Meza-Zepeda L.A., Eknaes M., Lind G.E.,
RA   Myklebost O., Skotheim R.I., Sveen A., Lothe R.A.;
RT   "Multi-omics of 34 colorectal cancer cell lines - a resource for
RT   biomedical studies.";
RL   Mol. Cancer 16:116-116(2017).
RX   PubMed=29101300; DOI=10.15252/msb.20177701;
RA   Frejno M., Zenezini Chiozzi R., Wilhelm M., Koch H., Zheng R.,
RA   Klaeger S., Ruprecht B., Meng C., Kramer K., Jarzab A., Heinzlmeir S.,
RA   Johnstone E., Domingo E., Kerr D., Jesinghaus M., Slotta-Huspenina J.,
RA   Weichert W., Knapp S., Feller S.M., Kuster B.;
RT   "Pharmacoproteomic characterisation of human colon and rectal
RT   cancer.";
RL   Mol. Syst. Biol. 13:951-951(2017).
RX   PubMed=29131639; DOI=10.1021/acs.jproteome.7b00548;
RA   Torres S., Garcia-Palmero I., Marin-Vicente C., Bartolome R.A.,
RA   Calvino E., Fernandez-Acenero M.J., Casal J.I.;
RT   "Proteomic characterization of transcription and splicing factors
RT   associated with a metastatic phenotype in colorectal cancer.";
RL   J. Proteome Res. 17:252-264(2018).
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
RX   PubMed=31059103; DOI=10.3892/or.2019.7146;
RA   Wang Y.-Y., Zhou L., Qing Q., Li Y.-F., Li L.-X., Dong X.-Y., Xiao B.;
RT   "Gene expression profile of cancer stemlike cells in the SW480 colon
RT   adenocarcinoma cell line.";
RL   Oncol. Rep. 42:386-398(2019).
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
RX   PubMed=31978347; DOI=10.1016/j.cell.2019.12.023;
RA   Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III,
RA   Kalocsay M., Jane-Valbuena J., Gelfand E., Schweppe D.K.,
RA   Jedrychowski M., Golji J., Porter D.A., Rejtar T., Wang Y.K.,
RA   Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A.,
RA   Sellers W.R., Gygi S.P.;
RT   "Quantitative proteomics of the Cancer Cell Line Encyclopedia.";
RL   Cell 180:387-402.e16(2020).
RX   PubMed=32172478; DOI=10.1007/s12253-020-00805-3;
RA   Xu Y.-T., Zhang L., Wang Q.-L., Zheng M.-J.;
RT   "Comparison of different colorectal cancer with liver metastases
RT   models using six colorectal cancer cell lines.";
RL   Pathol. Oncol. Res. 0:0-0(2020).